AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1

D-Valprax 250 ER Tablet

Prescription Icon
Prescription Required

Marketer

Avallac Pharmaceutical LLP

Salt Composition

Divalproex (250mg)

Overview D-Valprax 250 ER Tablet

Epileptic seizures and migraine prophylaxis are key applications of the extended-release D-Valprax 250mg tablet. It's also occasionally prescribed for bipolar disorder management, often in conjunction with other medications. Dosage and frequency are individually determined by your physician to optimize symptom control. Administer consistently, at the same time daily, with or without food, for maximal efficacy; therapeutic effects typically manifest within a fortnight. Continuous use, as directed, is crucial; discontinuation or missed doses may exacerbate the underlying condition and potentially trigger seizures; abrupt cessation is contraindicated. Common, generally mild, adverse effects encompass headache, visual blurring, nausea, vomiting, vertigo, fatigue, imbalance, easy bruising, and hypothermia. Persistent or troubling side effects warrant medical consultation, while skin rashes necessitate immediate physician notification. Prolonged therapy carries a risk of osteoporosis and increased fracture incidence. Suicidal ideation and behavior are rare but potential complications, requiring prompt medical attention if mood deteriorates. Prior to commencing treatment, disclose any pre-existing cardiac, renal, hepatic, urinary, depressive, or suicidal tendencies. Numerous drug interactions exist; comprehensive disclosure of all medications is vital to ensure treatment safety. Pregnancy necessitates physician consultation before initiating or altering therapy. Alcohol consumption should be avoided due to the potential for intensified side effects and heightened seizure risk. Regular blood monitoring, both pre- and post-treatment initiation, is typically necessary for optimal dose adjustment.

Uses of D-Valprax 250 ER Tablet

Managing epileptic seizures and bipolar disorder; migraine prevention.

Major Benefits of D-Valprax 250 ER Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for D-Valprax 250 ER Tablets. Ingest the tablets whole; avoid chewing, crushing, or breaking them. While D-Valprax 250 ER may be administered with or without food, consistent timing is recommended.

Common Side effects of D-Valprax 250 ER Tablet:

  • Decreased body temperature
  • Dizziness
  • Sleepiness
  • Tremors
  • Paresthesia (tingling or pricking sensation)
  • Anemia (low number of red blood cells)
  • Decreased sodium level in blood
  • Liver injury
  • Gastrointestinal disturbance
  • Hypersensitivity
  • Deafness
  • Urinary incontinence
  • Increase in body weight
  • Pain during periods

How to use D-Valprax 250 ER Tablet:

Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. D-Valprax 250 ER Tablets can be consumed with or without food, though consistent timing is recommended.

How D-Valprax 250 ER Tablet works:

Valproic acid extended-release 250mg tablets are used to manage epilepsy. This medication works by reducing hyperactivity within the brain's neuronal networks, thus preventing seizures.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concomitant use of D-Valprax 250 ER tablets and alcohol can lead to increased sleepiness.

PregnancyPregnancyCONSULT YOUR DOCTOR

Extended-release divalproex sodium 250 mg tablets pose a confirmed risk to a developing fetus and should not be taken during pregnancy. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Always seek medical advice.

Breast feedingBreast feedingSAFE IF PRESCRIBED

Extended-release valproic acid 250 mg tablets (e.g., D-Valprax) are considered safe for use while breastfeeding. Research in humans indicates minimal drug transfer to breast milk, posing no appreciable risk to the infant.

DrivingDrivingUNSAFE

Driving ability may be impaired by side effects associated with D-Valprax 250 ER Tablets.

KidneyKidneySAFE IF PRESCRIBED

Patients with kidney disease can safely take D-Valprax 250 ER tablets without requiring a dosage alteration.

LiverLiverUNSAFE

Extended-release divalproex sodium 250 mg tablets are contraindicated for individuals with hepatic impairment and should be omitted. Medical advice is recommended.

What if you forget to take D-Valprax 250 ER Tablet :

Should you forget a D-Valprax 250 ER Tablet dose, administer it promptly. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About D-Valprax 250 ER Tablet

LabelValue
Pharmaceutical Category Fatty acid-based compounds
Potential for Dependence None.
Type of Treatment Central and peripheral nervous system
Mechanism of Action Anticonvulsant drugs that target sodium channels

FAQs on D-Valprax 250 ER Tablet

Discontinuing D-Valprax 250 ER Tablet necessitates prior consultation with your physician. Withdrawal should occur under medical guidance, involving a phased reduction of dosage. Abrupt cessation may result in symptom reappearance, including agitation, nervousness, vertigo, and trembling.
D-Valprax 250 ER Tablets are occasionally prescribed to manage mood instability. Their use is indicated for individuals exhibiting rapid mood fluctuations. The therapeutic mechanism involves reducing excessive brain activity associated with these shifts in mood.
Weight gain is a potential side effect of D-Valprax 250 ER Tablets, possibly resulting from increased appetite. Regular exercise and a balanced diet can help mitigate this. Discuss any weight concerns with your physician.
Drowsiness is a possible side effect of D-Valprax 250 ER Tablets. Refrain from operating machinery or engaging in activities demanding concentration until you assess your individual response to the medication.
Hair loss is a potential side effect of D-Valprax 250 ER Tablets, typically temporary and dependent on dosage. Persistent or bothersome hair loss warrants medical attention.
Liver damage is a potential adverse effect of D-Valprax 250 ER Tablet. This risk is heightened within the initial six months of treatment. Indicators of potential liver injury may encompass nausea, vomiting, appetite suppression, abdominal pain, darkened urine, facial edema, and jaundice. Consequently, baseline liver function tests are recommended prior to commencing therapy, with subsequent periodic testing during the first six months, particularly for high-risk individuals or those with pre-existing hepatic conditions.
Refrain from drinking alcohol during your D-Valprax 250 ER Tablet treatment course. Concurrent alcohol use may increase drowsiness, lightheadedness, or dizziness.
Prior to commencing D-Valprax 250 ER Tablet treatment, your physician might recommend preliminary blood work. This may encompass a complete blood count (including platelets), bleeding time assessment, and coagulation studies. These evaluations help mitigate the risk of unexpected bleeding or bruising. Furthermore, pre-treatment liver function tests are advisable. Regular liver function monitoring is suggested during the initial six months of treatment, particularly for high-risk individuals and patients with a history of hepatic impairment.
Intense abdominal pain accompanied by nausea and vomiting could indicate pancreatitis. Seek immediate medical attention if these symptoms arise. Your physician may order a serum amylase test; a positive result necessitates immediate discontinuation of the medication.
An excess of D-Valprax 250 ER Tablets can lead to headaches, blurry vision resulting from constricted pupils, diminished reflexes, disorientation, and fatigue. Further symptoms may include muscle weakness or hypotonia, convulsions, unconsciousness, altered behavior, and respiratory problems like tachypnea, dyspnea, or chest pain. Seek immediate medical attention if an overdose occurs.
D-Valprax 250 ER Tablet
71
MRP 87
18% off